Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis
- PMID: 30624662
- DOI: 10.1093/annonc/mdy535
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis
Erratum for
-
Adverse events risk associated with bevacizumab addition to breast cancer chemotherapy: a meta-analysis.Ann Oncol. 2012 May;23(5):1130-1137. doi: 10.1093/annonc/mdr432. Epub 2011 Oct 4. Ann Oncol. 2012. PMID: 21976387
Publication types
LinkOut - more resources
Full Text Sources
